Get the Stockscreener App
84.11
2.14%
-1.84
After Hours:
84.00
-0.11
-0.13%
Billiontoone Inc stock is traded at $84.11, with a volume of 283.57K.
It is down -2.14% in the last 24 hours and down -18.02% over the past month.
BillionToOne Inc is a precision diagnostics company revolutionizing molecular testing with its patented Quantitative Counting Templates (QCT) platform. This technology enables ultrasensitive, single-molecule DNA quantification, making genetic testing more accurate, affordable, and accessible. The company serves prenatal screening and oncology markets with non-invasive tests that detect fetal genetic risks and monitor cancer therapy response.
See More
Previous Close:
$85.95
Open:
$84.14
24h Volume:
283.57K
Relative Volume:
1.74
Market Cap:
$3.85B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-10.87%
1M Performance:
-18.02%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$80.00
$86.50
1-Week Range:
$80.00
$96.84
52-Week Range:
$80.00
$138.70
Billiontoone Inc Stock (BLLN) Company Profile
Name
Billiontoone Inc
Sector
Industry
Phone
-
Address
-
Compare BLLN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BLLN
Billiontoone Inc
|
84.11 | 3.93B | 0 | 0 | 0 | 0.00 |
|
TMO
Thermo Fisher Scientific Inc
|
636.30 | 232.57B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
242.05 | 165.52B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
696.46 | 54.78B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
241.40 | 39.80B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
139.77 | 38.51B | 6.95B | 1.30B | 1.15B | 4.5696 |
Billiontoone Inc Stock (BLLN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-26 | Initiated | Guggenheim | Buy |
| Dec-01-25 | Initiated | BTIG Research | Buy |
| Dec-01-25 | Initiated | JP Morgan | Overweight |
| Dec-01-25 | Initiated | Jefferies | Hold |
| Dec-01-25 | Initiated | Piper Sandler | Overweight |
| Dec-01-25 | Initiated | Stifel | Buy |
| Dec-01-25 | Initiated | Wells Fargo | Equal Weight |
| Dec-01-25 | Initiated | William Blair | Outperform |
View All
Billiontoone Inc Stock (BLLN) Latest News
Analysts Offer Insights on Healthcare Companies: BillionToOne, Inc. Class A (BLLN) and Dexcom (DXCM) - The Globe and Mail
BillionToOne Inc (BLLN) Trading Down 4.99% on Jan 20 - GuruFocus
BillionToOne Inc (BLLN) Stock Price Down 3.55% on Jan 16 - GuruFocus
BillionToOne integrates prenatal and oncology tests with Epic EHR By Investing.com - Investing.com Nigeria
BillionToOne Integrates Prenatal and Oncology Tests into Epic Aura Diagnostics Suite - TipRanks
BillionToOne to Integrate Testing Portfolio With Epic's Diagnostics Suite - marketscreener.com
BillionToOne, Inc. Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Across Healthcare - marketscreener.com
BillionToOne integrates prenatal and oncology tests with Epic EHR - Investing.com
BillionToOne Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Across Healthcare - PR Newswire
What's Going On With BillionToOne Shares Tuesday?BillionToOne (NASDAQ:BLLN) - Benzinga
BillionToOne reaffirms 2025 guidance, projects 40-45% revenue growth in 2026 - Investing.com Nigeria
BillionToOne Stock (+15%): Strong '26 Guidance Spurs Re-Rate - Trefis
BillionToOne: Reaffirmed Growth Targets and Upside to 2026 Support Reiterated Buy Rating - TipRanks
BillionToOne reaffirms FY25 guidance - MSN
(BLLN) BillionToOne Expects 2026 Total Revenue Range $415M to $430M, vs. FactSet Est of $402.3M - marketscreener.com
BillionToOne Issues Strong 2026 Growth and Profit Outlook - TipRanks
Billiontoone provides guidance for 2026 - marketscreener.com
BillionToOne Provides Guidance for 2026 - The Manila Times
Billiontoone Provides Guidance For 2026 - TradingView — Track All Markets
Billiontoone, Inc. Provides Earnings Guidance for 2026 - marketscreener.com
BillionToOne, Inc. (NASDAQ:BLLN) Q3 2025 earnings call transcript - MSN
BillionToOne initiated with a Buy at Stifel - MSN
BillionToOne, Inc.: Revenue and Earnings Analysts Forecasts Revisions | BPJH | US0901681058 - marketscreener.com
January 2026's Top Growth Companies With Insider Confidence - Yahoo Finance
After tax other income/expense of BillionToOne, Inc. Class A – BX:BLLN - TradingView — Track All Markets
BillionToOne initiated with a buy at Guggenheim - MSN
BillionToOne, Inc. Announces Selection of Northstar Select as New Liquid Biopsy Test for LC-SCRUM-TRY Clinical Study at National Cancer Center Hospital East - marketscreener.com
BillionToOne Announces Selection of Northstar Select® as the new - GuruFocus
BillionToOne Announces Selection of Northstar Select® as the new liquid biopsy test for LC-SCRUM-TRY clinical study at National Cancer Center Hospital East - PR Newswire
3 Stocks Estimated To Be Up To 48.4% Below Intrinsic Value - Yahoo Finance
BillionToOne (BLLN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
BillionToOne Earnings Notes - Trefis
Med-tech IPOs shoot for the stars in 2025 - BioWorld MedTech
BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference - 富途牛牛
2 New IPO Stocks Enter the Fray; J.P. Morgan Says ‘Buy’ - Yahoo Finance
BillionToOne stock in focus before Monday open after Friday jump, JPMorgan conference next - ts2.tech
BillionToOne (BLLN) Stock Update: Friday Rally, Analyst Price Targets, and the Next Catalysts Before Nasdaq Reopens - ts2.tech
BillionToOne Stock (NASDAQ: BLLN) News: Weekend Market Wrap, Analyst Targets, and What to Watch Before Monday’s Open - ts2.tech
BillionToOne Stock (NASDAQ: BLLN) Rises Into the Weekend as Analyst Targets Point Higher — What Investors Need to Know Before Monday - ts2.tech
Should I buy BillionToOne, Inc. (BLLN) - Zacks Investment Research
Evommune and BillionToOne climb on trading debut - MSN
BillionToOne (BLLN) Is Down 6.7% After Joining the S&P Total Market IndexWhat's Changed - simplywall.st
BillionToOne falls -5.5% - MSN
BillionToOne: An Interesting Set-Up Into 2026 - Seeking Alpha
BillionToOne Stock (NASDAQ: BLLN) News, Forecasts, and Analyst Outlook for December 22, 2025 - ts2.tech
BillionToOne Adds Genmab CFO Anthony Pagano to Board, Names Him Audit Chair - TipRanks
Analysts Are Bullish on These Healthcare Stocks: Gilead Sciences (GILD), BillionToOne, Inc. Class A (BLLN) - The Globe and Mail
Billiontoone Inc Stock (BLLN) Financials Data
There is no financial data for Billiontoone Inc (BLLN). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.80%
3.61%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):